These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19664323)

  • 1. [Nasopharyngeal carcinoma in sub-Saharan Africa: a tribute to Mr. Peter Clifford].
    Griffin BE
    Ai Zheng; 2009 Aug; 28(8):785-90. PubMed ID: 19664323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus (EBV) and human disease: facts, opinions and problems.
    Griffin BE
    Mutat Res; 2000 Apr; 462(2-3):395-405. PubMed ID: 11523539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burkitt's Lymphoma.
    Rochford R; Moormann AM
    Curr Top Microbiol Immunol; 2015; 390(Pt 1):267-85. PubMed ID: 26424650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus and cancers of the head and neck.
    Goldenberg D; Golz A; Netzer A; Rosenblatt E; Rachmiel A; Goldenberg RF; Joachims HZ
    Am J Otolaryngol; 2001; 22(3):197-205. PubMed ID: 11351290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus encoded BALF1 gene is transcribed in Burkitt's lymphoma cell lines and in nasopharyngeal carcinoma's biopsies.
    Cabras G; Decaussin G; Zeng Y; Djennaoui D; Melouli H; Broully P; Bouguermouh AM; Ooka T
    J Clin Virol; 2005 Sep; 34(1):26-34. PubMed ID: 16087121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of squamous cell carcinomas of the nasopharynx with Epstein-Barr virus shows geographical variation reminiscent of Burkitt's lymphoma.
    Nicholls JM; Agathanggelou A; Fung K; Zeng X; Niedobitek G
    J Pathol; 1997 Oct; 183(2):164-8. PubMed ID: 9390028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
    Abdulkarim B; Sabri S; Zelenika D; Deutsch E; Frascogna V; Klijanienko J; Vainchenker W; Joab I; Bourhis J
    Oncogene; 2003 Apr; 22(15):2260-71. PubMed ID: 12700662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burkitt's lymphoma and emerging therapeutic strategies for EBV and AIDS-associated lymphoproliferative diseases in East Africa.
    Mwanda WO; Whalen C; Remick SC
    East Afr Med J; 2005 Sep; 82(9 Suppl):S133-4. PubMed ID: 16619688
    [No Abstract]   [Full Text] [Related]  

  • 9. Epstein-Barr virus: 40 years on.
    Young LS; Rickinson AB
    Nat Rev Cancer; 2004 Oct; 4(10):757-68. PubMed ID: 15510157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The investigation of Epstein-Barr viral sequences in 41 cases of Burkitt's lymphoma from Egypt: epidemiologic correlations.
    Anwar N; Kingma DW; Bloch AR; Mourad M; Raffeld M; Franklin J; Magrath I; el Bolkainy N; Jaffe ES
    Cancer; 1995 Oct; 76(7):1245-52. PubMed ID: 8630905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus and carcinogenesis: beyond Burkitt's lymphoma.
    Shah KM; Young LS
    Clin Microbiol Infect; 2009 Nov; 15(11):982-8. PubMed ID: 19874382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic role of Epstein-Barr virus in human cancer.
    Takada K; Shimizu N; Tanabe-Tochikura A; Kuroiwa Y
    Intervirology; 1995; 38(3-4):214-20. PubMed ID: 8682619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism analysis of Epstein-Barr virus isolates of nasopharyngeal carcinoma biopsies from Tunisian patients.
    Ayadi W; Feki L; Khabir A; Boudawara T; Ghorbel A; Charfeddine I; Daoud J; Frikha M; Hammami A; Karray-Hakim H
    Virus Genes; 2007 Apr; 34(2):137-45. PubMed ID: 17216568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus mir-bart1-5p detection via nasopharyngeal brush sampling is effective for diagnosing nasopharyngeal carcinoma.
    Zheng XH; Lu LX; Cui C; Chen MY; Li XZ; Jia WH
    Oncotarget; 2016 Jan; 7(4):4972-80. PubMed ID: 26701721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quantitative and localized detection of Epstein-Barr virus infectious status in nasopharyngeal carcinoma tissue].
    Jiang WH; Zhao SP; Yin ZH; Li F; Chen ZH; Xiao JY
    Ai Zheng; 2005 Jul; 24(7):796-800. PubMed ID: 16004803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The relation between EB virus and Burkitt's lymphoma].
    Gao Z; Lu H; Liao S
    Zhonghua Bing Li Xue Za Zhi; 1997 Apr; 26(2):106-7. PubMed ID: 10072883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus and the pathogenesis of Burkitt's lymphoma: more questions than answers.
    Bornkamm GW
    Int J Cancer; 2009 Apr; 124(8):1745-55. PubMed ID: 19165855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral immune response in Epstein-Barr virus infections. II. IgG subclass distribution in African patients with Burkitt's lymphoma and nasopharyngeal carcinoma.
    Kaschka WP; Klein G; Hilgers R; Skvaril F
    Clin Exp Immunol; 1984 Jan; 55(1):14-22. PubMed ID: 6319056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic markers for Epstein-Barr virus in the control of nasopharyngeal carcinoma and Burkitt lymphoma.
    Levine PH
    Cancer Detect Prev Suppl; 1987; 1():217-23. PubMed ID: 2826001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus, the TCL-1 oncogene and Burkitt's lymphoma.
    Bell A; Rickinson AB
    Trends Microbiol; 2003 Nov; 11(11):495-7. PubMed ID: 14607063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.